Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Houyanqing Oral Liquid for Preventing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma
NCT07311772Phase 3Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Dec 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Houyanqing Oral Liquid in oral mucositis (OM), sponsored by Sun Yat-sen University. Started Dec 2025; status: recruiting.
02
Drugs
Houyanqing Oral Liquid
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT07311772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07311772.